About Jerini
Jerini is a Healthcare company based in Berlin (Germany). Peptide-based therapeutics are developed for multiple diseases. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.
Company details
Peptide-based therapeutics are developed by the company, based in Berlin, Germany, targeting various diseases in the biotechnology sector. Firazyr is provided for acute attacks of hereditary angioedema. JSM 6427 serves as an α5β1 integrin antagonist for cancer and age-related macular degeneration. JSM-7717 and JPE-1375 function as C5a receptor antagonists for inflammatory and ophthalmological conditions. Operations focus on research and product development in these therapeutic areas.
- Headquarters Berlin, Germany
- SectorsHealthcare
- Website jerini.de
Web traffic of Jerini
Websites that share an audience with Jerini (jerini.de).
Websites whose visitors overlap most with Jerini. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
synprosis.com | synprosis.com | 100% | β | ||
dfccan.com | dfccan.com | 100% | β | ||
acscientific.com | acscientific.com | 100% | β | ||
| peptidesynthetics.co.uk | 100% | #2,566,929 | View details | ||
| synbiosci.com | 100% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 15 similar websites and full traffic analytics for Jerini
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Jerini
Jerini is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Peptide-based therapeutics are developed by the company, based in Berlin, Germany, targeting various diseases in the biotechnology sector. Firazyr is provided for acute attacks of hereditary angioedema. JSM 6427 serves as an Ξ±5Ξ²1 integrin antagonist for cancer and age-related macular degeneration. JSM-7717 and JPE-1375 function as C5a receptor antagonists for inflammatory and ophthalmological conditions. Operations focus on research and product development in these therapeutic areas.